NasdaqGS:NVAXBiotechs
The Bull Case For Novavax (NVAX) Could Change Following Shah Capital’s Activist Governance Challenge - Learn Why
On May 15, 2026, Shah Capital Management disclosed that it had sent an “Elevating Novavax” presentation to Novavax’s board, criticizing leadership over marketing since 2023, the Sanofi partnership, capital markets decisions, and executive pay practices.
This intervention signals rising shareholder pressure around governance and capital allocation, potentially increasing expectations for management or board changes at Novavax.
With Shah Capital challenging Novavax’s leadership and partnership...